Publicaciones en las que colabora con Juan Francisco Navarro González (49)

2022

  1. Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  3. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

    Nefrologia, Vol. 42, Núm. 6, pp. 645-655

2021

  1. Increased SGK1 activity potentiates mineralocorticoid/NaCl-induced kidney injury

    American journal of physiology. Renal physiology, Vol. 320, Núm. 4, pp. F628-F643

2019

  1. Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

    Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 313-321

2016

  1. Urinary Clara Cell Protein in Kidney Transplant Patients: A Preliminary Study

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2884-2887

2015

  1. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: The PREDIAN trial

    Journal of the American Society of Nephrology, Vol. 26, Núm. 1, pp. 220-229

2012

  1. Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study

    BMC Nephrology, Vol. 13, Núm. 1

2010

  1. Erdheim-Chester disease as cause of end-stage renal failure: A case report and review of the literature

    International Urology and Nephrology, Vol. 42, Núm. 4, pp. 1107-1112

  2. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 182, Núm. 8, pp. 1004-1010

2007

  1. Implicaciones de la inflamación en la lesión renal secundaria a la diabetes mellitus

    Implicaciones de la inflamación en la lesión renal secundaria a la diabetes mellitus

2006

  1. Trombocitopenia inducida por heparina en hemodiálisis. Presentación de un caso y revisión de la literatura

    Nefrologia, Vol. 26, Núm. 6, pp. 734-737

2003

  1. Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients: A short-term, prospective, randomized study

    American Journal of Kidney Diseases, Vol. 42, Núm. 2, pp. 264-270

  2. Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis

    American Journal of Medicine, Vol. 114, Núm. 1, pp. 62-64

  3. Fracaso renal y hepático asociado al uso de cianamida

    Anales de medicina interna, Vol. 20, Núm. 11, pp. 603

  4. Fracaso renal y hepático asociado al uso de cianamida

    Anales de Medicina Interna

  5. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

    American Journal of Kidney Diseases, Vol. 42, Núm. 1 SUPPL. 2, pp. 53-61

2002

  1. Randomized prospective comparison between erythropoietin and androgens in CAPD patients

    Kidney International, Vol. 61, Núm. 4, pp. 1537-1544

  2. Virus emergentes en nefrología: Poliomavirus

    Nefrologia, Vol. 22, Núm. 5, pp. 414-424

2001

  1. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients

    Peritoneal Dialysis International, Vol. 21, Núm. 6, pp. 611-614